Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3693353019 | Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | en | Synonym | Active | Case insensitive | SNOMED CT core |
3693354013 | Product containing precisely heparinoid 2 milligram/1 gram and salicylic acid 20 milligram/1 gram conventional release transdermal cream (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Is a | Heparinoid and salicylic acid only product in transdermal dose form | true | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Plays role | Antifungal therapeutic role | true | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Is a | Salicylic acid product | false | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has active ingredient | Keratolytic agent | false | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has active ingredient | Salicylic acid | false | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has active ingredient | Heparinoid | false | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Is a | Salicylic acid-containing product | false | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Is a | Heparinoid-containing product | false | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has active ingredient | Topical agent | false | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has manufactured dose form | Cream | false | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has manufactured dose form | Transdermal cream | true | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has precise active ingredient | Salicylic acid | true | Inferred relationship | Some | 2 | |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength numerator value | 20 | false | Inferred relationship | Some | 2 | |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has BoSS | Salicylic acid | true | Inferred relationship | Some | 2 | |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has precise active ingredient | Heparinoid | true | Inferred relationship | Some | 1 | |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has BoSS | Heparinoid | true | Inferred relationship | Some | 1 | |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Has concentration strength numerator value | 2 | false | Inferred relationship | Some | 1 | |
Heparinoid 2 mg/g and salicylic acid 20 mg/g transdermal cream | Is a | Heparinoid- and salicylic acid-containing product in transdermal dose form | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets